Both in Pharmaceuticals
Dyne Therapeutics vs Acadia Pharmaceuticals
Over the past year DYN returned −29.8% and ACAD returned −12.0%; their daily moves had a correlation of 0.32.
DYN −29.8% ACAD −12.0%Growth of $1, one year, split-adjusted
| Metric | DYN | ACAD |
|---|---|---|
| Price | $16.98 | $20.24 |
| Market cap | $3.17B | $3.49B |
| Today | +0.21% | +0.32% |
| 1 month | +4.7% | +0.1% |
| 6 months | −2.5% | −8.9% |
| Year to date | −13.2% | −24.2% |
| 1 year | −29.8% | −12.0% |
| Revenue growth (YoY) | — | +16.4% |
| Gross margin | — | 90.8% |
| Net margin | — | 10.2% |
| P/E (TTM) | — | 9.2× |
| Price / sales | — | 3.1× |
| Net cash | $685.0M | $956.5M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 45.9% |
| Short % of float | 14.6% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).